Figure 4
![Figure 4. Effect of treatment on late bacterial infection. Treatment effect estimated from Cox model adjusted for disease status and stem-cell source (HR [ATG-F vs control]= 0.68, 95% CI, 0.39-1.17, P = .16).](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/117/23/10.1182_blood-2011-01-329821/4/zh89991171840004.jpeg?Expires=1743237507&Signature=4ODJ1j3OF8BwqlA5JMAZ2gsu4DJm4Gl1TbL4Ux71KaOAJAg8LOnUHPylvmTNhmqrqNia3CxiwFFSpq-WU4SpIaYb4rOlG9XEXOhA21B9KPRXZKsKSGzwOOp~Elzn4wFHfyXiEMXbwNIFg8QXMAPHnjP5ZayYzYl5nqDDNtUzGXMqWq22mGidZc4o4CODIA62pn1WzkqHOo9C-LTRjDi2brI2lOxmPP2BH~i0IA4IgBl-ufAjSaVTZkQt7zX4F5IDRMnvDzJohjAT0kyU3uFq8--bdRf4geFRth05dPof-X93Jw4Fho2ZFPuJSaRbmZvOkmyYtFpVztZNOVmIto4a4Q__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Effect of treatment on late bacterial infection. Treatment effect estimated from Cox model adjusted for disease status and stem-cell source (HR [ATG-F vs control]= 0.68, 95% CI, 0.39-1.17, P = .16).
Effect of treatment on late bacterial infection. Treatment effect estimated from Cox model adjusted for disease status and stem-cell source (HR [ATG-F vs control]= 0.68, 95% CI, 0.39-1.17, P = .16).
